Review articleBisphosphonates: A review of their pharmacokinetic properties
References (96)
- et al.
Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models
Bone
(1995) - et al.
Importance of the paracellular pathway for the transport of a new bisphosphate using the human Caco-2 monolayers model
Pharmacol Biochem
(1993) - et al.
Measurements of intestinal permeability using low molecular weight polyethylene glycol (PEG 400) 1. Chemical analysis and biological properties of (PEG 400)
Gastroenterology
(1977) - et al.
Measurements of intestinal permeability using low molecular weight polyethylene glycos (PEG 400). 2. Application to normal and abnormal permeability states in man and animals
Gastroenterology
(1977) - et al.
Plasma protein binding of APD: Role of calcium and transferrin
Chem Biol Interact
(1992) - et al.
Assay of 1-hydroxy-3-aminopropylidene-1, 1-bisphosphonate and related bisphosphonates in human urine and plasma by high performance ion chromatography
J Chromatogr
(1989) - et al.
Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition
Metab Bone Dis Rel Res
(1984) - et al.
Kinetics of trabecular bone resorption and formation in hypothyroidism: evidence for a positive balance per remodeling cycle
Bone
(1986) - et al.
Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, highperformance liquid chromatography and fluorescence detection
J Chromatogr
(1989) - et al.
Improved determination of the bisphosphonate alendronate in human plasma and urine by automated precolumn derivatization and high-performance liquid chromatography with fluorescence and electrochemical detection
J Chromatogr
(1992)
Protein binding of small molecules I. Effect of pH and inorganic salts on the combination of phenol red with proteins
Biochem Biophys Acta
(1973)
On the absorption of alendronate in rats
J Pharm Sci
(1994)
Metabolism of disodium ethane-1-hydroxy-1, 1-diphosphonate (disodium etidronate) in the rat, rabbit, dog and monkey
Toxicol Appl Pharmacol
(1972)
Intestinal absorption of disodium ethane-1-hydroxyl-1-diphosphonate (disodium eidronate) using a deconvolution technique
Toxicol Appl Pharmacol
(1973)
Paracellular transport of inorganic and organic ions across the rat ileum
Biochem Pharmacol
(1983)
Renal secretion of diphosphonates in rats
Kidney Int
(1975)
Cytotoxic effects of pamidronate on monolayers of human intestinal epithelial (Caco-2) cells and its epithelial transport
J Pharm Sci
(1994)
Excursions in the field of SAR: a consideration of the past, the present and the future
Optimalization of pharmacokinetics-An essential aspect of drug development
Electrical phenomena and ion transport in the small intestine
Calcium-regulating hormones: parathyroid hormone and calcitonin
APD in Paget's disease of bone. Role of mononuclear phagocyte system?
Arth Rheum
(1980)
Clodronate kinetics and dynamics
Clin Pharmacol Ther
(1981)
A comparison of the pharmacokinetics of 14C-labelled APD and 99m Tc-labelled ADP in the mouse
Calcif Tissue Int
(1988)
The clearance and bioavailability of pamidronate in patients with breast cancer and bone metastases
Calcif Tissue Int
(1991)
Trabecular bone remodeling and bone balance in hyperthyroidism
Bone
(1984)
Pamidronate: a review of its pharmacological properties and therapeutic efficiency in resorptive bone disease
Drugs
(1991)
Bisphosphonates. Mechanism of action and clinical applications
Bone and mineral metabolism
Diphosphonates
Calcif Tissue Int
(1979)
The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution of calcium phosphate in vitro and in vivo
Calcif Tissue Res
(1968)
Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo
Science
(1969)
Pyrophosphate and polyphosphate
Effect of pyrophosphonate on hydroxyapatite and its implications in calcium homeostasis
Nature
(1966)
Absorption of oral disphosphonates in normal subjects
Clin Endocrinol
(1986)
Clinical pharmacology of alendronate sodium
Osteopor Int
(1993)
Absorption kinetics and bioavailability
Renal transport of drugs. Renal transport of organic substances
Dosedependent absorption of disodium etidronate
J Pharm Pharmacol
(1985)
Pharmacokinetics of disodium clodronate after daily intravenous infusions during five consecutive days
Int J Clin Pharmacol Ther Toxicol
(1989)
A model for the pH dependency of drug-protein binding
J Pharm Pharmacol
(1981)
The renal excretion of drugs
Glucose effects on intestinal drug absorption: contributions of microclimate pH and paracellular pathway
Pharmacokinetic evaluation of pamidronate after oral administration: a study on dose proportionality, absolute bioavailability, and effect of repeated administration
Calcif Tissue Int
(1993)
Sodium EDTA enhances intestinal absorption of two bisphosphonates
Calcif Tissue lot
(1991)
Selective flame emission detection of phosphorus and sulfur in high-performance liquid chromatography
J Chromatogr
(1975)
The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals
Calcif Tissue Res
(1973)
Structure-function relationships in bone: an examination of events at the cellular level
Cited by (824)
Integrating osteoimmunology and nanoparticle-based drug delivery systems for enhanced fracture healing
2024, Nanomedicine: Nanotechnology, Biology, and MedicineEngineering small-molecule and protein drugs for targeting bone tumors
2024, Molecular TherapyNanotechnologies and controlled release formulations for the administration of bisphosphonates and their potential in radiation protection
2023, Journal of Drug Delivery Science and TechnologyReview of the Mechanism of Action and Use of Bisphosphonates in Horses
2023, Journal of Equine Veterinary Science
Copyright © 1996 Published by Elsevier Inc.